Moderna, Inc.
Moderna, Inc. 0QF.F Peers
See (0QF.F) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 0QF.F | $23.00 | -1.01% | 8.89B | -2.99 | -$7.70 | N/A |
| NOV.DE | $58.65 | -3.58% | 259.84B | 18.62 | $3.15 | +1.04% |
| VX1.DE | $391.85 | +0.11% | 100.63B | -116.97 | -$3.35 | N/A |
| DUL.DE | $227.20 | N/A | 27.27B | -31.91 | -$7.12 | N/A |
| 22UA.F | $86.20 | -2.38% | 20.72B | -27.02 | -$3.19 | N/A |
| BM8.DE | $61.96 | -1.71% | 11.76B | 88.51 | $0.70 | N/A |
| EX9.DE | $32.28 | +1.22% | 9.21B | 35.47 | $0.91 | N/A |
| MOR.DE | $67.25 | -0.66% | 2.53B | -12.16 | -$5.53 | N/A |
| BBZA.DE | $30.75 | -1.44% | 1.68B | 12.55 | $2.45 | +6.51% |
| BIO3.DE | $30.00 | N/A | 1.45B | 45.45 | $0.66 | N/A |
Stock Comparison
0QF.F vs NOV.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, NOV.DE has a market cap of 259.84B. Regarding current trading prices, 0QF.F is priced at $23.00, while NOV.DE trades at $58.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas NOV.DE's P/E ratio is 18.62. In terms of profitability, 0QF.F's ROE is -0.30%, compared to NOV.DE's ROE of +0.85%. Regarding short-term risk, 0QF.F is less volatile compared to NOV.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs VX1.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, VX1.DE has a market cap of 100.63B. Regarding current trading prices, 0QF.F is priced at $23.00, while VX1.DE trades at $391.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas VX1.DE's P/E ratio is -116.97. In terms of profitability, 0QF.F's ROE is -0.30%, compared to VX1.DE's ROE of -0.03%. Regarding short-term risk, 0QF.F is more volatile compared to VX1.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs DUL.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, DUL.DE has a market cap of 27.27B. Regarding current trading prices, 0QF.F is priced at $23.00, while DUL.DE trades at $227.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas DUL.DE's P/E ratio is -31.91. In terms of profitability, 0QF.F's ROE is -0.30%, compared to DUL.DE's ROE of +9.05%. Regarding short-term risk, 0QF.F is more volatile compared to DUL.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs 22UA.F Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, 22UA.F has a market cap of 20.72B. Regarding current trading prices, 0QF.F is priced at $23.00, while 22UA.F trades at $86.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas 22UA.F's P/E ratio is -27.02. In terms of profitability, 0QF.F's ROE is -0.30%, compared to 22UA.F's ROE of -0.03%. Regarding short-term risk, 0QF.F is more volatile compared to 22UA.F. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs BM8.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, BM8.DE has a market cap of 11.76B. Regarding current trading prices, 0QF.F is priced at $23.00, while BM8.DE trades at $61.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas BM8.DE's P/E ratio is 88.51. In terms of profitability, 0QF.F's ROE is -0.30%, compared to BM8.DE's ROE of +0.08%. Regarding short-term risk, 0QF.F is more volatile compared to BM8.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs EX9.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, EX9.DE has a market cap of 9.21B. Regarding current trading prices, 0QF.F is priced at $23.00, while EX9.DE trades at $32.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas EX9.DE's P/E ratio is 35.47. In terms of profitability, 0QF.F's ROE is -0.30%, compared to EX9.DE's ROE of +0.24%. Regarding short-term risk, 0QF.F is less volatile compared to EX9.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs MOR.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, MOR.DE has a market cap of 2.53B. Regarding current trading prices, 0QF.F is priced at $23.00, while MOR.DE trades at $67.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas MOR.DE's P/E ratio is -12.16. In terms of profitability, 0QF.F's ROE is -0.30%, compared to MOR.DE's ROE of +4.15%. Regarding short-term risk, 0QF.F is more volatile compared to MOR.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs BBZA.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, BBZA.DE has a market cap of 1.68B. Regarding current trading prices, 0QF.F is priced at $23.00, while BBZA.DE trades at $30.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas BBZA.DE's P/E ratio is 12.55. In terms of profitability, 0QF.F's ROE is -0.30%, compared to BBZA.DE's ROE of +0.05%. Regarding short-term risk, 0QF.F is less volatile compared to BBZA.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs BIO3.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, BIO3.DE has a market cap of 1.45B. Regarding current trading prices, 0QF.F is priced at $23.00, while BIO3.DE trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas BIO3.DE's P/E ratio is 45.45. In terms of profitability, 0QF.F's ROE is -0.30%, compared to BIO3.DE's ROE of +0.05%. Regarding short-term risk, 0QF.F is more volatile compared to BIO3.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs BIO.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, BIO.DE has a market cap of 1.44B. Regarding current trading prices, 0QF.F is priced at $23.00, while BIO.DE trades at $42.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas BIO.DE's P/E ratio is 64.85. In terms of profitability, 0QF.F's ROE is -0.30%, compared to BIO.DE's ROE of +0.05%. Regarding short-term risk, 0QF.F is more volatile compared to BIO.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs IMU.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, IMU.DE has a market cap of 1.14B. Regarding current trading prices, 0QF.F is priced at $23.00, while IMU.DE trades at $5.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas IMU.DE's P/E ratio is -9.22. In terms of profitability, 0QF.F's ROE is -0.30%, compared to IMU.DE's ROE of -0.93%. Regarding short-term risk, 0QF.F is less volatile compared to IMU.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs NVV1.F Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, NVV1.F has a market cap of 905.09M. Regarding current trading prices, 0QF.F is priced at $23.00, while NVV1.F trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas NVV1.F's P/E ratio is -5.17. In terms of profitability, 0QF.F's ROE is -0.30%, compared to NVV1.F's ROE of +0.31%. Regarding short-term risk, 0QF.F is more volatile compared to NVV1.F. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs GBY.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, GBY.DE has a market cap of 884.70M. Regarding current trading prices, 0QF.F is priced at $23.00, while GBY.DE trades at $5.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas GBY.DE's P/E ratio is -4.38. In terms of profitability, 0QF.F's ROE is -0.30%, compared to GBY.DE's ROE of -2.75%. Regarding short-term risk, 0QF.F is more volatile compared to GBY.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs 5CV.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, 5CV.DE has a market cap of 733.11M. Regarding current trading prices, 0QF.F is priced at $23.00, while 5CV.DE trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas 5CV.DE's P/E ratio is 4.52. In terms of profitability, 0QF.F's ROE is -0.30%, compared to 5CV.DE's ROE of +0.29%. Regarding short-term risk, 0QF.F is more volatile compared to 5CV.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs 5CV.F Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, 5CV.F has a market cap of 713.74M. Regarding current trading prices, 0QF.F is priced at $23.00, while 5CV.F trades at $3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas 5CV.F's P/E ratio is 4.40. In terms of profitability, 0QF.F's ROE is -0.30%, compared to 5CV.F's ROE of +0.29%. Regarding short-term risk, 0QF.F is more volatile compared to 5CV.F. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs 2EM.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, 2EM.DE has a market cap of 585.99M. Regarding current trading prices, 0QF.F is priced at $23.00, while 2EM.DE trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas 2EM.DE's P/E ratio is 34.38. In terms of profitability, 0QF.F's ROE is -0.30%, compared to 2EM.DE's ROE of +0.20%. Regarding short-term risk, 0QF.F is more volatile compared to 2EM.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs FYB.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, FYB.DE has a market cap of 408.93M. Regarding current trading prices, 0QF.F is priced at $23.00, while FYB.DE trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas FYB.DE's P/E ratio is -3.22. In terms of profitability, 0QF.F's ROE is -0.30%, compared to FYB.DE's ROE of -0.24%. Regarding short-term risk, 0QF.F is less volatile compared to FYB.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs 2VSA.F Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, 2VSA.F has a market cap of 347.56M. Regarding current trading prices, 0QF.F is priced at $23.00, while 2VSA.F trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas 2VSA.F's P/E ratio is -2.09. In terms of profitability, 0QF.F's ROE is -0.30%, compared to 2VSA.F's ROE of -5.83%. Regarding short-term risk, 0QF.F is less volatile compared to 2VSA.F. This indicates potentially lower risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs 88Q.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, 88Q.DE has a market cap of 201.13M. Regarding current trading prices, 0QF.F is priced at $23.00, while 88Q.DE trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas 88Q.DE's P/E ratio is -14.13. In terms of profitability, 0QF.F's ROE is -0.30%, compared to 88Q.DE's ROE of +3.45%. Regarding short-term risk, 0QF.F is more volatile compared to 88Q.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs VSC.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, VSC.DE has a market cap of 150.70M. Regarding current trading prices, 0QF.F is priced at $23.00, while VSC.DE trades at $2.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas VSC.DE's P/E ratio is -7.27. In terms of profitability, 0QF.F's ROE is -0.30%, compared to VSC.DE's ROE of -0.90%. Regarding short-term risk, 0QF.F is more volatile compared to VSC.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs HPHA.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, HPHA.DE has a market cap of 147.73M. Regarding current trading prices, 0QF.F is priced at $23.00, while HPHA.DE trades at $3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas HPHA.DE's P/E ratio is -7.73. In terms of profitability, 0QF.F's ROE is -0.30%, compared to HPHA.DE's ROE of -0.63%. Regarding short-term risk, 0QF.F is more volatile compared to HPHA.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs IF0.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, IF0.DE has a market cap of 129.91M. Regarding current trading prices, 0QF.F is priced at $23.00, while IF0.DE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas IF0.DE's P/E ratio is -2.43. In terms of profitability, 0QF.F's ROE is -0.30%, compared to IF0.DE's ROE of -0.66%. Regarding short-term risk, 0QF.F is more volatile compared to IF0.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs 94E.F Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, 94E.F has a market cap of 68.68M. Regarding current trading prices, 0QF.F is priced at $23.00, while 94E.F trades at $1.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas 94E.F's P/E ratio is -2.09. In terms of profitability, 0QF.F's ROE is -0.30%, compared to 94E.F's ROE of -0.37%. Regarding short-term risk, 0QF.F is more volatile compared to 94E.F. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs BNN.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, BNN.DE has a market cap of 45.22M. Regarding current trading prices, 0QF.F is priced at $23.00, while BNN.DE trades at $2.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas BNN.DE's P/E ratio is -3.63. In terms of profitability, 0QF.F's ROE is -0.30%, compared to BNN.DE's ROE of -1.08%. Regarding short-term risk, 0QF.F is more volatile compared to BNN.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs C6O.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, C6O.DE has a market cap of 13.19M. Regarding current trading prices, 0QF.F is priced at $23.00, while C6O.DE trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas C6O.DE's P/E ratio is -0.05. In terms of profitability, 0QF.F's ROE is -0.30%, compared to C6O.DE's ROE of +1.21%. Regarding short-term risk, 0QF.F is less volatile compared to C6O.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs GBMB.F Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, GBMB.F has a market cap of 12.56M. Regarding current trading prices, 0QF.F is priced at $23.00, while GBMB.F trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas GBMB.F's P/E ratio is -0.08. In terms of profitability, 0QF.F's ROE is -0.30%, compared to GBMB.F's ROE of -0.67%. Regarding short-term risk, 0QF.F is more volatile compared to GBMB.F. This indicates potentially higher risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs CNW.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, CNW.DE has a market cap of 6.55M. Regarding current trading prices, 0QF.F is priced at $23.00, while CNW.DE trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas CNW.DE's P/E ratio is -0.44. In terms of profitability, 0QF.F's ROE is -0.30%, compared to CNW.DE's ROE of -0.49%. Regarding short-term risk, 0QF.F is less volatile compared to CNW.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs LD6.F Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, LD6.F has a market cap of 4.36M. Regarding current trading prices, 0QF.F is priced at $23.00, while LD6.F trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas LD6.F's P/E ratio is -1.01. In terms of profitability, 0QF.F's ROE is -0.30%, compared to LD6.F's ROE of -3.29%. Regarding short-term risk, 0QF.F is less volatile compared to LD6.F. This indicates potentially lower risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs MDG1.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, MDG1.DE has a market cap of 1.97M. Regarding current trading prices, 0QF.F is priced at $23.00, while MDG1.DE trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas MDG1.DE's P/E ratio is -0.11. In terms of profitability, 0QF.F's ROE is -0.30%, compared to MDG1.DE's ROE of -0.58%. Regarding short-term risk, 0QF.F is less volatile compared to MDG1.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 0QF.F.
0QF.F vs T5O.DE Comparison
0QF.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0QF.F stands at 8.89B. In comparison, T5O.DE has a market cap of 164400.00. Regarding current trading prices, 0QF.F is priced at $23.00, while T5O.DE trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0QF.F currently has a P/E ratio of -2.99, whereas T5O.DE's P/E ratio is -0.25. In terms of profitability, 0QF.F's ROE is -0.30%, compared to T5O.DE's ROE of -1.91%. Regarding short-term risk, 0QF.F is less volatile compared to T5O.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 0QF.F.